- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Pancreatic Neuroendocrine Tumor in Canada
Total 413 results
-
University Health Network, TorontoRecruitingSolid Tumors and Metastatic LesionsCanada
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Salspera LLCActive, not recruiting
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
British Columbia Cancer AgencyThe Alfred; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Cancer... and other collaboratorsRecruitingMetastatic TumorsCanada, Australia, United Kingdom, Ireland
-
McGill University Health Centre/Research Institute...Completed
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
Triumvira Immunologics, Inc.RecruitingMetastatic Solid TumorUnited States, Canada
-
Grupo Espanol de Tumores NeuroendocrinosPfizer; Threshold PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine TumorsSpain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Alpha Tau Medical LTD.RecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic CancerCanada
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
Sunnybrook Health Sciences CentreCompletedCarcinoma, NeuroendocrineCanada
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Symphogen A/SActive, not recruitingSolid Tumor | Metastatic CancerUnited States, Canada, France, Spain
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditionsCanada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in the Bone | Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | Metastatic Malignant Neoplasm in the Lung | Metastatic Ewing Sarcoma | Metastatic Malignant Neoplasm in the Bone Marrow | Metastatic Peripheral Primitive Neuroectodermal Tumor of BoneUnited States, Canada, Puerto Rico
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia
-
Maxim PharmaceuticalsNational Cancer Institute (NCI)UnknownMetastatic Cancer | Melanoma (Skin)United States, Canada, Germany, United Kingdom
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
University of AlbertaRecruiting
-
University Health Network, TorontoCompleted
-
University of AlbertaRecruitingNeuroendocrine TumorsCanada
-
AHS Cancer Control AlbertaRecruiting
-
BioNTech SETerminatedGastric Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Canada
-
Centre de recherche du Centre hospitalier universitaire...Université de SherbrookeRecruiting
-
University Health Network, TorontoActive, not recruitingNeuroendocrine TumorsCanada
-
Centre de recherche du Centre hospitalier universitaire...Completed
-
Sunnybrook Health Sciences CentreMerck KGaA, Darmstadt, GermanyUnknown
-
University Health Network, TorontoCompletedNeuroendocrine TumorsCanada
-
British Columbia Cancer AgencyCanadian Cancer Society (CCS); SignalChem Lifesciences CorporationTerminatedMetastatic Pancreatic Ductal AdenocarcinomaCanada
-
John LenehanNot yet recruitingUnresectable or Metastatic Advanced Pancreatic Ductal AdenocarcinomaCanada
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerCanada
-
Vancouver Coastal HealthUnknownNeuroblastoma | Pheochromocytoma | Paraganglioma | Medullary Thyroid Carcinoma | Carcinoid TumorsCanada
-
University of AlbertaRecruitingParkinson Disease | Brain Tumor | Neuroendocrine Tumors | Lewy Body Disease | Neuroblastoma | Congenital HyperinsulinismCanada
-
AHS Cancer Control AlbertaUnknown
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
University Health Network, TorontoCancer Care Ontario; Ozmosis Research Inc.; Canadian Molecular Imaging Probe...Active, not recruitingNeuroendocrine TumorsCanada
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
British Columbia Cancer AgencyRecruitingProstatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | ParagangliomaCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbTerminatedMetastatic MelanomaUnited States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
-
British Columbia Cancer AgencyCompleted